BIOMAT Database Logo BIOMAT Database Logo

Preliminary report of clinical experience with sulfadimethoxine, a new long-acting sulfonamide. 1958

E H TOWNSEND, and A BORGSTEDT

UI MeSH Term Description Entries
D000077145 Sulfanilamide A short-acting sulfonamide used as an anti-infective agent. It has lower anti-bacterial activity than SULFAMETHOXAZOLE. 4-aminobenzenesulfonamide,Azol Polvo,Sulfanilamide Barium Salt,Sulfanilamide Cadmium Salt,Sulfanilamide Hydrochloride,Sulfanilamide Lithium Salt,Sulfanilamide Magnesium Salt,Sulfanilamide Monohydrate,Sulfanilamide Silver Salt,Sulfanilamide Sodium,Sulfanilamide Sodium Salt,Sulfanilamide Strontium Salt,Sulfanilamide Zinc Salt,Sulphanilamide,4 aminobenzenesulfonamide
D013412 Sulfadimethoxine A sulfanilamide that is used as an anti-infective agent. Deposul,Sulphadimethoxine
D013424 Sulfanilamides Compounds based on 4-aminobenzenesulfonamide. The '-anil-' part of the name refers to aniline. Sulphanilamides
D013449 Sulfonamides A group of compounds that contain the structure SO2NH2. Sulfonamide,Sulfonamide Mixture,Sulfonamide Mixtures,Mixture, Sulfonamide,Mixtures, Sulfonamide
D016219 Immunotherapy, Adoptive Form of adoptive transfer where cells with antitumor activity are transferred to the tumor-bearing host in order to mediate tumor regression. The lymphoid cells commonly used are lymphokine-activated killer (LAK) cells and tumor-infiltrating lymphocytes (TIL). This is usually considered a form of passive immunotherapy. (From DeVita, et al., Cancer, 1993, pp.305-7, 314) Adoptive Cellular Immunotherapy,Adoptive Immunotherapy,CAR T-Cell Therapy,Cellular Immunotherapy, Adoptive,Chimeric Antigen Receptor Therapy,Immunotherapy, Adoptive Cellular,Adoptive Cellular Immunotherapies,Adoptive Immunotherapies,CAR T Cell Therapy,CAR T-Cell Therapies,Cellular Immunotherapies, Adoptive,Immunotherapies, Adoptive,Immunotherapies, Adoptive Cellular,T-Cell Therapies, CAR,T-Cell Therapy, CAR,Therapies, CAR T-Cell,Therapy, CAR T-Cell

Related Publications

E H TOWNSEND, and A BORGSTEDT
[A new long-acting sulfonamide; sulfadimethoxine (madribon)].
August 1959, Schweizerische medizinische Wochenschrift,
E H TOWNSEND, and A BORGSTEDT
[Clinical experience with a new delayed sulfonamide: sulfadimethoxine].
April 1960, Minerva medica,
E H TOWNSEND, and A BORGSTEDT
Sulfadimethoxine, a new long-acting sulfonamide; some preliminary clinical and laboratory observations in infants and children.
January 1958, Antibiotics annual,
E H TOWNSEND, and A BORGSTEDT
[Clinical experience with a new long-acting sulfonamide in pediatrics].
May 1959, Prensa medica argentina,
E H TOWNSEND, and A BORGSTEDT
[Clinical experience with a new, long acting sulfonamide (sulfamethoxypyridazine or lederkyn)].
October 1958, Munchener medizinische Wochenschrift (1950),
E H TOWNSEND, and A BORGSTEDT
[Experience with a new long-acting sulfonamide in vaginal surgery].
May 1960, La Semana medica,
E H TOWNSEND, and A BORGSTEDT
[Report of experience in the use of a new long-acting type of sulfonamide].
August 1958, Deutsche medizinische Wochenschrift (1946),
E H TOWNSEND, and A BORGSTEDT
Clinical trial of a new long acting sulfonamide-sulfamethoxypyridazine.
June 1958, Indian journal of medical sciences,
E H TOWNSEND, and A BORGSTEDT
[Preliminary clinical experience with a new sulfonamide at low dosage].
May 1961, Minerva medica,
E H TOWNSEND, and A BORGSTEDT
A clinical trial with Piloplex--a new long-acting pilocarpine compound: preliminary report.
April 1979, Annals of ophthalmology,
Copied contents to your clipboard!